Nakajima, K.; Iwata, H.; Hattori, Y.; Nomura, K.; Hayashi, K.; Toshito, T.; Umemoto, Y.; Hashimoto, S.; Ogino, H.; Shibamoto, Y.
Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer. Cancers 2022, 14, 517.
https://doi.org/10.3390/cancers14030517
AMA Style
Nakajima K, Iwata H, Hattori Y, Nomura K, Hayashi K, Toshito T, Umemoto Y, Hashimoto S, Ogino H, Shibamoto Y.
Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer. Cancers. 2022; 14(3):517.
https://doi.org/10.3390/cancers14030517
Chicago/Turabian Style
Nakajima, Koichiro, Hiromitsu Iwata, Yukiko Hattori, Kento Nomura, Kensuke Hayashi, Toshiyuki Toshito, Yukihiro Umemoto, Shingo Hashimoto, Hiroyuki Ogino, and Yuta Shibamoto.
2022. "Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer" Cancers 14, no. 3: 517.
https://doi.org/10.3390/cancers14030517
APA Style
Nakajima, K., Iwata, H., Hattori, Y., Nomura, K., Hayashi, K., Toshito, T., Umemoto, Y., Hashimoto, S., Ogino, H., & Shibamoto, Y.
(2022). Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer. Cancers, 14(3), 517.
https://doi.org/10.3390/cancers14030517